-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q2 2024.
- X4 Pharmaceuticals, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 201M shares, a 19% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 178M shares, a 180% increase from 2022.
- X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 63.5M shares, a 147% increase from 2021.
- X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 25.7M shares, a 28.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)